This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

SGLT2i Versus DPP-4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events

SGLT2 Inhibitors Reduce CKD Progression Across All Kidney Function Levels: JAMA

Australia: A new meta-analysis has found that SGLT2 inhibitors significantly lower the risk of chronic kidney disease (CKD) progression regardless of...
View All

Latest News and Guidelines

Weight Training Outperforms Running for Weight Loss, Diabetes Control, Study Finds

Weight Training Outperforms Running for Weight Loss, Diabetes Control, Study Finds

CDSCO Panel Asks Regenix to Submit Additional Trial Data for Insulin Injection Approval

Hyperinsulinemia Independently Linked to Coronary Microvascular Disease, reveals research

Study finds no hypoglycemia risk: Breastfeeding Safe for At-Risk Neonates Despite Lower Glucose Levels

Study finds no hypoglycemia risk: Breastfeeding Safe for At-Risk Neonates Despite Lower Glucose...

Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide

Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide

Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

Diabetes

Heart Drug Verapamil May Cut Risk of Type 2 Diabetes, New Research Suggests

View All
X